A System for Remote Monitoring of Chronic Lung Disease of Infancy (CLDI)

描述（由申请人提供）：这个拟议的项目旨在开发技术，以促进从新生儿重症监护病房（NICU）过渡的婴儿的护理。该技术的重点是监测与婴儿慢性肺病（CLDI）相关的疾病，CLDI是一组通常由新生儿急性呼吸系统疾病演变而来的呼吸系统疾病。围产期护理的进步、卫生保健经济学的变化以及表明长期住院对早产儿发育有负面影响的研究影响了CLDI婴儿的出院做法。越来越多的人认识到，家庭环境是医学上稳定的、技术辅助的婴儿接受他们所需的复杂和苛刻护理的最佳环境。新生儿重症监护室的婴儿通常连接到多个设备和监视器。虽然这种挽救生命的技术是为这些婴儿提供护理的必要组成部分，但许多电线也会增加照顾这些婴儿的复杂性，特别是在没有受过训练的人员的家庭环境中。电子元件的最新进展使微型无线医疗仪器得以开发，其尺寸和重量适合新生儿可穿戴应用。第一阶段计划将开发无线仪器。计划进行二期临床研究。

DESCRIPTION (provided by applicant): This proposed project aims to develop technology that facilitates care of infants that are typically in transition from a neonatal intensive care unit (NICU). The focus of this technology is to monitor the conditions associated with chronic lung disease of infancy (CLDI), a group of respiratory diseases that usually evolves from an acute respiratory disorder experienced by a newborn infant. Advances in perinatal care, changes in health care economics, and research suggesting a negative impact of prolonged hospitalization on development of the preterm newborn have influenced discharge practices for infants with CLDI. The home environment has increasingly been recognized as the optimal setting for medically stable, technology assisted infants to receive the complex and demanding care they require. Infants in the NICU are commonly connected to multiple pieces of equipment and monitors. While this lifesaving technology is a necessary part of providing care to these infants, the many wires can also add to the complexity of caring for these infants, particularly in a home environment with untrained personnel. Very recent advances in electronic components allow miniature wireless medical instrumentation to be developed that are of a size and weight appropriate for a wearable neonate application. The phase I program will develop wireless instrumentation. A clinical study is planned for phase II. PUBLIC HEALTH RELEVANCE: Chronic lung disease of infancy (CLDI) is a group of pulmonary disorders that start in the neonatal period. Often the inciting factor is bronchopulmonary dysplasia (BPD), a chronic condition that usually evolves after premature birth and respiratory distress syndrome due to surfactant deficiency. BPD is the most common pulmonary morbidity in preterm infants and affects approximately 5,000 to 10,000 infants in the United States each year